[Read](/names) · [Unpick](/preparations) · [Carry](/borders)

[Peptide Int](/)

# The name travels with its preparation.

Recognising a name is a good feeling. I still want to know what comes after it. A cream, a tablet and an injection aren’t details to tuck away at the end of the conversation.

How the body meets a substance

## Route

![A rolled sheet of reddish copper lies on stone beside an adult’s resting forearm, without touching it.](/int-continuation-3dce088ccebe/skin-at-the-sleeve.webp)

Copper is part of the name GHK-Cu. Raw metal isn’t a peptide preparation.

Route means how a substance is used in or on the body. Topical means on the surface. Intranasal means through the nose. Evidence about one route doesn’t automatically answer questions about another.

Copper Tripeptide-1 is the cosmetic ingredient name for GHK-Cu. Copper is part of that name, but the metal alone isn’t the peptide. Its skincare use doesn’t establish that an injection is safe or approved. FDA explains [the cosmetic rules](https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated) separately from its [safety concerns for injectable GHK-Cu](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks). I keep that route attached to the name.

On FDA’s page current as of April 22, 2026, the injectable entry appears among nominations that were withdrawn. That means the request was taken back. It isn’t clearance, Category 1 placement or approval for compounding. FDA’s safety concerns, including possible immune reactions, remain.

The route is one detail; the chemical form is another.

The ingredient named more precisely

## Form

A salt is a particular chemical form. Semaglutide sodium and semaglutide acetate are examples. FDA says they’re [different active ingredients from the one in approved semaglutide drugs](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss), and it knows of no lawful basis for using those salts in compounding. The extra word changes the description.

Semaglutide has approved tablets and injections. Its [prescribing information covers those forms](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b). Knowing the ingredient’s name doesn’t make the forms interchangeable, and a compounded preparation isn’t FDA-approved. I read the full preparation name, even when the first word looks familiar.

The label also describes [nausea, vomiting and other stomach problems](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), plus serious warnings. Its thyroid-tumour warning comes from findings in rodents; the risk in people is unknown. Those medical details belong in a conversation about the particular medicine and person.

The form belongs inside the full preparation name.

What the finished description includes

## Preparation

Compounding means preparing a medicine for a particular need under the applicable rules. Compounded drugs aren’t FDA-approved. As FDA’s [explanation makes clear](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers), it doesn’t check their safety, effectiveness or quality before they’re marketed. The process isn’t an approval stamp.

BPC-157 shows why the exact identity matters too. FDA’s [review found inconsistent chemical naming](https://www.fda.gov/media/193343/download), raising the possibility of receiving a different substance than intended. Its small human studies also leave safety and benefits unresolved. A familiar nickname can’t settle either problem.

A licensed U.S. clinician can discuss appropriate, lawful options, including approved medicines where they exist. An online appointment doesn’t change ingredient eligibility. The [borders page](/borders) follows that question into U.S. access rules.

The preparation now has enough detail to meet the access rules.

Peptide Int is my guide to peptide language; it is not a clinic, a pharmacy or a seller.

[References](/references) · [Sport](/sport) · [About](/about) · [Contact](/contact)

© 2026 Peptide Int